HealthEquity founder receives stock awards
HEALTHEQUITY, INC. founder and vice chairman Stephen Neeleman reported equity compensation awards rather than open‑market trades.
Rhea-AI Filing Summary
HEALTHEQUITY, INC. founder and vice chairman Stephen Neeleman reported equity compensation awards rather than open‑market trades. On March 25, 2026, he received 15,915 restricted stock units, each representing one common share, with 25% vesting on April 1, 2027 and 6.25% quarterly for the next twelve quarters.
He also acquired 23,860 shares of common stock as restricted stock units that vested on March 25, 2026, bringing his directly held common shares to 150,519. Separate option holdings remain outstanding, covering additional shares at exercise prices of $41.28, $61.72 and $73.61 with expirations between 2027 and 2029.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 39,775 shares
Grant/Award
8 txns
Insider
Neeleman Stephen
Role
FOUNDER AND VICE CHAIRMAN
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 15,915 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 23,860 | $0.00 | $0.00 |
| holding | Stock Option (right to buy) | -- | -- | -- |
| holding | Stock Options (right to buy) | -- | -- | -- |
| holding | Stock Options (right to buy) | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 150,519 shares (Direct);
Stock Option (right to buy) — 19,897 contracts (Direct);
Stock Options (right to buy) — 29,565 contracts (Direct);
Common Stock — 752,735 shares (Indirect, See footnote)
Footnotes (6)
- F1. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Shares vest as to 25% of the initial award on April 1, 2027. Shares shall vest as to 6.25% thereafter on the first day of each calendar quarter for the twelve calendar quarters following April 1, 2027.
- F2. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vested as to 23,860 shares on March 25, 2026.
- F3. Shares held of record by the Stephen and Christine Neeleman Trust.
- F4. The securities are beneficially owned by the Reporting Person's spouse. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.
- F5. Shares held of record by Neeleman Family Holdings, LLC ("Family Holdings"), a Utah limited liability company. The reporting person is the manager of Family Holdings. The reporting person disclaims beneficial ownership of the shares held by Family Holdings except to the extent of his pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of the shares held by Family Holdings for any other purposes.
- F6. The option is immediately exercisable.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did HealthEquity (HQY) founder Stephen Neeleman acquire in this Form 4?
Stephen Neeleman received equity compensation, not open‑market purchases. He was granted 15,915 restricted stock units and 23,860 common shares from vested restricted stock units on March 25, 2026, increasing his directly held common stock position as reported in the filing.
What is the vesting schedule for Stephen Neeleman’s new HealthEquity (HQY) restricted stock units?
The 15,915 restricted stock units vest over time. Twenty‑five percent of the initial award vests on April 1, 2027, then 6.25% of the units vest on the first day of each calendar quarter for the twelve calendar quarters following April 1, 2027, subject to award terms.
Which HealthEquity (HQY) restricted stock units vested for Stephen Neeleman on March 25, 2026?
Restricted stock units representing 23,860 shares of HealthEquity common stock vested for Stephen Neeleman on March 25, 2026. Each restricted stock unit corresponds to one share, so vesting converted these units into directly held shares as reflected in his updated ownership totals.
What stock options does Stephen Neeleman still hold in HealthEquity (HQY)?
He holds several stock option positions, each immediately exercisable. These options relate to 19,897, 14,228 and 15,337 underlying common shares, with exercise prices of $41.28, $61.72 and $73.61 respectively, and expiration dates ranging from March 27, 2027 to March 26, 2029.
How are Stephen Neeleman’s indirect HealthEquity (HQY) holdings structured?
Indirect holdings are reported through multiple entities and relationships. Shares are held by the Stephen and Christine Neeleman Trust, by his spouse, and by Neeleman Family Holdings, LLC. He disclaims beneficial ownership for his spouse’s shares and for the LLC beyond his pecuniary interest.
AI-generated analysis. How Rhea-AI works. Not financial advice.
